1. | strawberrynut11 | |
2. | ps7geek | |
3. | konstas49 | |
4. | sahuebner | |
5. | wolf3489 |
1. | strawberrynut11 | |
2. | ps7geek | |
3. | konstas49 | |
4. | sahuebner | |
5. | wolf3489 |
1. | konstas49 03/07/2018 JMP Securities reiterates Outperform rating; PT raised to $20 from $11 |
2. | strawberrynut11 06/25/2018 Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to-Control Type 2 Diabetes |
3. | strawberrynut11 03/07/2018 Announces positive interim data from ongoing ZGN-1061 Phase 2 proof-of-concept trial in patients with Type 2… |